U.S. Software Stock News

Thinking about what to do with your Euronet Worldwide shares, or wondering if now is the moment to jump in? You are not alone. Euronet’s stock price has turned a few heads recently, climbing 5.1% this past week after a stretch marked by choppiness. After a negative swing of 1.7% over the last month and a bigger slide of 13.6% year-to-date, the recent uptick has many investors asking whether this is finally the bounce they have been waiting for or just another blip. Over longer stretches,...

Thinking about what to do next with BioLife Solutions stock? You are not alone. Over the past year, shares have quietly climbed 15.6%, and while that performance might catch your eye, it is the bigger context that makes this stock so interesting right now. Investors have watched it rebound 6.8% in just the last 30 days, adding to a 4.4% gain year-to-date. Yet, when looking further back, the five-year total return lags at -5.9%, painting a far more complex picture. So, what is driving this...

Enerpac Tool Group (EPAC) posted a five-year annual earnings growth rate of 38.3%, while its net profit margin climbed to 15% from last year’s 13.9%. More recently, the company’s earnings growth over the past twelve months slowed to 12.8%, and forecasts point to further moderation, with annual earnings growth expected at 11.4% versus the broader US market’s 15.6%. With revenue growth forecasts slightly trailing industry averages, the spotlight remains on strong profit margins and a share...

If you’re wondering what to do with Trex Company stock, you’re definitely not alone. After all, who hasn’t noticed how the price has bounced around over the past year? Trex, known for its eco-friendly composite decking, has seen its share price dip by 25.7% year-to-date, and it’s still down more than 21% over the last twelve months. It’s not just short-term volatility, either. Over the past five years, the stock is off by an eye-catching 33.8%. This creates an interesting situation for some...

Thinking about Terex stock and not quite sure whether to buy, hold, or sell? You’re definitely not alone. After all, this equipment manufacturer has given investors a real rollercoaster in recent years, mixing strong multi-year returns with the occasional dip. Over the last five days, Terex bounced up 5.0%, and it’s gone nearly sideways in the past month with just a 0.8% uptick. Year to date, though, the stock is up an impressive 19.1%, hinting at a resurgence in investor confidence or...

American Battery Technology, which had been counting on a major government grant to help fund a new lithium hydroxide plant, saw its stock tumble after the US Department of Energy terminated the award. The company is appealing the decision but says its plans remain unchanged for now. See our latest analysis for American Battery Technology. Despite hitting major technical milestones and publishing an encouraging Pre-Feasibility Study on its lithium project, American Battery Technology shares...

Thinking about what to do with Fastenal stock right now? It's a good question, and plenty of investors are wrestling with it. After all, Fastenal has had a remarkable run over the last few years: up 98.9% in the past 3 years and 114.8% in the last 5. However, the last month has been rough, with the stock sliding 9.9% and a 7.3% dip just in the last week. Even with these recent hiccups, it’s still showing an impressive 19.4% year-to-date gain and is 11.3% higher than it was a year ago. Market...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

If you’re wondering what to do about Manhattan Associates stock at this crossroads, you’re in good company. The once high-flying supply chain software specialist has caught the attention of investors trying to make sense of recent swings. Despite an impressive 54.3% three-year return and a remarkable 101.9% gain over five years, the stock is now catching its breath. Over the past month, shares have slipped by 8.4%, pushing year-to-date performance down to -26.8%, with a full-year drop to...

Cryoport, Inc. recently unveiled new integrated condition monitoring solutions for its MVE Biological Solutions dewars, incorporating the SmartTag and CryoBeacon devices powered by Tec4Med, with data centralized in the FDA-compliant MVECloud platform for enhanced monitoring of cryogenic storage. This innovation offers life sciences companies real-time visibility and improved safety for temperature-sensitive commodities, reflecting an ongoing push toward advanced digital and compliance...

Webster Financial (WBS) posted a net profit margin of 33.4%, rising from last year’s 32.4%, with five-year average earnings growth of 25.5% per year. While near-term earnings growth slowed to 5.8%, analyst consensus and models show the stock is trading at $54.27, well below its estimated fair value of $124.88 and the average analyst target. Valuation measures like a 10.9x P/E make it look attractive compared to peers and the industry. Investors are likely to focus on the high quality of...

Quantum-Si recently introduced its V4 Sequencing Kit, designed to enhance protein analysis by expanding sequencing coverage and improving detection of specific amino acids. This technological advance stands out for its potential to significantly strengthen the company’s protein sequencing platform in the evolving life sciences sector. We'll look at how the V4 Sequencing Kit's improved capabilities shape Quantum-Si's investment narrative amid shifting market attention. Find companies with...

American Express (AXP) posted earnings growth of 3.2% for the latest year, a slowdown from its five-year average of 16.4% annually. Net profit margins dipped to 15.8%, down from 16.7% the prior year, and the company’s expected revenue growth of 9.2% per year lags behind the broader US market’s 10.1% forecast. With steady profit and revenue growth forecasts remaining in place, investors now face a moderation in momentum and margins as the company trades at a Price-to-Earnings Ratio of 24.1x,...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

AVITA Medical (RCEL) shares have drawn attention after Chairman Cary Vance was named Interim CEO, replacing Jim Corbett. This leadership shift comes as preliminary third-quarter revenue comes in below expectations and ongoing talks with lenders continue. See our latest analysis for AVITA Medical. Shares of AVITA Medical have struggled through 2025, with the 1-day share price return plunging 25.84% after the CEO transition and softer revenue update. Short-term momentum has clearly faded. With...

Ramaco Resources, Inc. ( NASDAQ:METC ) shares have continued their recent momentum with a 76% gain in the last month...

Opendoor Technologies Inc. ( NASDAQ:OPEN ) shares have retraced a considerable 30% in the last month, reversing a fair...

Key Insights Williams Companies' estimated fair value is US$68.22 based on 2 Stage Free Cash Flow to Equity With...

We'd be surprised if Byrna Technologies Inc. ( NASDAQ:BYRN ) shareholders haven't noticed that the Independent...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Western Digital Corporation ( NASDAQ:WDC ) shares have continued their recent momentum with a 25% gain in the last...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Trying to figure out what’s next for PTC Therapeutics? You’re not alone. Whether you’re holding shares, eyeing an entry, or just want to keep tabs on one of biotech’s more intriguing players, let’s dig in. Over the past month, the stock has put on a show, rising 8.7%. Zoom out a bit further and you’ll spot a year-to-date surge of 43.7%, with a hefty 68.7% jump over the past year. That’s more than just a good run, and it has caught the market’s attention, especially as broader industry...